WorldCat Identities

Shkreli, Martin

Overview
Works: 3 works in 5 publications in 1 language and 365 library holdings
Genres: Television news programs  Nonfiction television programs 
Publication Timeline
.
Most widely held works by Martin Shkreli
[Hedge-fund manager Martin Shkreli, founder of Turing Pharmaceuticals, responds to accusations that he was greedy in raising the price of Daraprim, a taxoplasmosis drug] by Don Dahler( Recording )

1 edition published in 2015 in English and held by 1 WorldCat member library worldwide

Hedge-fund manager Martin Shkreli, founder of Turing Pharmaceuticals, responds to accusations that he was greedy in raising the price of Daraprim, a taxoplasmosis drug, from $13.50 to $750 a tablet. Shkreli says that the profit his company garners from the price increase will allow for increased research into new drugs. Oncologist David Agus responds to Shkreli's claims, asserting that patients should not pay for prospective research when buying a life saving drug. On "This morning."
 
Audience Level
0
Audience Level
1
  Kids General Special  
Audience level: 0.28 (from 0.28 for Once upon ... to 0.71 for [Hedge-fun ...)

Alternative Names
Martin Shkreli americký podnikatel

Martin Shkreli Amerikaans ondernemer

Martin Shkreli Amerikansk forretningsmann

Martin Shkreli US-amerikanischer Hedgefondsmanager

Мартин Шкрели американский предприниматель

Мартін Шкрелі

مارتن شكريلي رائد أعمال من الولايات المتحدة الأمريكية

مارتین شکرلی

مارتین شکرئلی

마틴 슈크렐리

ማርቲን ሽክረሊ

マーティン・シャリ

Languages